Ecor1 Capital, LLC’s Nuvation Bio Inc Position
Does Ecor1 Capital, LLC own Nuvation Bio Inc (NUVB)? Not currently — the last reported position was 19.21M shares worth $44M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$44M
Q3 2024
Shares
19.21M
% of Portfolio
+1.51%
Quarters Held
15
position exited
Position History NUVB
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 19.21M | $44M | +1.51% |
| Q2 2024 | 19.21M | $56M | +1.72% |
| Q1 2024 | 19.21M | $70M | +1.77% |
| Q4 2023 | 19.21M | $29M | +0.75% |
| Q3 2023 | 19.21M | $26M | +0.87% |
| Q2 2023 | 13.90M | $25M | +0.61% |
| Q1 2023 | 13.90M | $23M | +0.74% |
| Q4 2022 | 13.90M | $27M | +0.81% |
| Q3 2022 | 13.90M | $31M | +0.92% |
| Q2 2022 | 13.90M | $45M | +1.55% |
| Q1 2022 | 13.90M | $73M | +2.29% |
| Q4 2021 | 13.90M | $118M | +3.76% |
| Q3 2021 | 13.71M | $136M | +4.74% |
| Q2 2021 | 13.71M | $128M | +4.77% |
| Q1 2021 | 13.25M | $138M | +6.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ecor1 Capital, LLC’s full portfolio or all institutional holders of NUVB.